Azithromycin 500 mg 7-Day Regimen Indications

Community-Acquired Lower Respiratory Tract Infections

The European Respiratory Society recommends treating community-acquired lower respiratory tract infections (except pneumonia) for at least 7 days when using antibiotics other than clarithromycin and azithromycin 1
For community-acquired pneumonia managed in the hospital setting, azithromycin is typically given as 500 mg daily for 3 days or 500 mg on day 1 followed by 250 mg daily for 5 days 4
When treating severe community-acquired pneumonia, particularly in patients with risk factors or comorbidities, a longer 7-day course may be warranted 2
For suspected Legionella pneumophila infections, treatment should last 10-14 days, with immunocompromised patients potentially requiring longer therapy 2

The combination of atovaquone plus azithromycin for 7-10 days is recommended as initial therapy for babesiosis, with azithromycin dosed at 500-1000 mg on day 1 and 250 mg once daily thereafter 3
For immunocompromised patients with babesiosis, higher doses of azithromycin (600-1000 mg per day) may be used 3

Azithromycin should not be administered concomitantly with aluminum- or magnesium-containing antacids as they reduce absorption 8
Before initiating azithromycin therapy, especially in patients with cardiac risk factors, an ECG should be performed to assess QTc interval, and avoid azithromycin if QTc is >450 ms for men and >470 ms for women 7

For severe infections or in immunocompromised hosts, extending therapy to 7 days may be necessary to ensure complete eradication 3